Comparison between MCON Rasayan IPO and Sudarshan Pharma Industries IPO.
MCON Rasayan IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Sudarshan Pharma Industries IPO is a SME Bookbuilding proposed to list at BSE SME.
| MCON Rasayan IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Econo Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of MCON Rasayan IPO is up to ₹6.48 Cr whereas the issue size of the Sudarshan Pharma Industries IPO is up to ₹47.58 Cr. The final issue price of MCON Rasayan IPO is ₹40.00 per share and of Sudarshan Pharma Industries IPO is ₹73.00 per share.
| MCON Rasayan IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹71.00 per share | |
| Issue Price (Upper) | ₹73.00 per share | |
| Issue Price (Final) | ₹40.00 per share | ₹73.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1600 shares |
| Fresh Issue Size | 16,20,000 shares | 65,18,400 shares |
| Fresh Issue Size (Amount) | up to ₹6.48 Cr | up to ₹47.58 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 16,20,000 shares | 65,18,400 shares |
| Issue Size Total (Amount) | up to ₹6.48 Cr | up to ₹47.58 Cr |
MCON Rasayan IPO opens on Mar 06, 2023, while Sudarshan Pharma Industries IPO opens on Mar 09, 2023. The closing date of MCON Rasayan IPO and Sudarshan Pharma Industries IPO is Mar 10, 2023, and Mar 14, 2023, respectively.
| MCON Rasayan IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Anchor Bid Date | Mar 08, 2023 | |
| Issue Open | Mar 06, 2023 | Mar 09, 2023 |
| Issue Close | Mar 10, 2023 | Mar 14, 2023 |
| Basis Of Allotment (Tentative) | Mar 15, 2023 | Mar 17, 2023 |
| Initiation of Refunds (Tentative) | Mar 16, 2023 | Mar 20, 2023 |
| Credit of Share (Tentative) | Mar 17, 2023 | Mar 21, 2023 |
| Listing date (Tentative) | Mar 20, 2023 | Mar 22, 2023 |
| Anchor Lockin End date 1 | Apr 16, 2023 | |
| Anchor Lockin End date 2 | Jun 15, 2023 |
MCON Rasayan IPO P/E ratio is 14.71, as compared to Sudarshan Pharma Industries IPO P/E ratio of 24.33.
| MCON Rasayan IPO | Sudarshan Pharma Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.45 | 80.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.64 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.71 | 24.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹25.22 Cr. | ₹175.68 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06 | 17.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 9.93 | 38.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 3.35 | 1.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.96 | ₹5.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.06 | 17.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the MCON Rasayan IPO Retail Individual Investors (RII) are offered 8,10,000 shares while in Sudarshan Pharma Industries IPO retail investors are offered 8,10,000 shares. Qualified Institutional Buyers (QIB) are offered in MCON Rasayan IPO and 5,21,600 shares in Sudarshan Pharma Industries IPO.
| MCON Rasayan IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,80,800 shares | |
| Market Maker Reservation | 90,000 shares | 3,44,000 shares |
| QIB | 5,21,600 shares | |
| NII | 8,10,000 shares | 15,64,800 shares |
| RII | 8,10,000 shares | 36,51,200 shares |
| Employee | ||
| Others | ||
| Total | 16,20,000 shares | 65,18,400 shares |
MCON Rasayan IPO subscribed 384.64x in total, whereas Sudarshan Pharma Industries IPO subscribed 1.06x.
| MCON Rasayan IPO | Sudarshan Pharma Industries IPO | |
|---|---|---|
| QIB (times) | 1.01x | |
| NII (times) | 307.09x | 0.81x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 453.41x | 1.20x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 384.64x | 1.06x |
